Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFenikso Limited Regulatory News (FNK.PL)

Share Price Information for Fenikso Limited (FNK.PL)

Share Price is delayed by 15 minutes
Get Live Data
1.65    0.00 (0.00%)
Bid:
1.40
Ask:
1.90
Spread: 0.50 (35.714%)
Market Cap: £8.13m
FNK.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Fenikso Limited Share Chart

Transaction In Own Shares

14 May 2025 07:00

RNS Number : 5358I
Fenikso Limited
14 May 2025
 

This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

14 May 2025

 

 

Fenikso Limited

 

("Fenikso" or "the Company")

 

Transaction In Own Shares

 

Fenikso Limited (AQSE: FNK) announces that, pursuant to the share buyback programme (the "Programme") announced on 28th October 2024, it acquired the following number of ordinary shares of US$0.00005 each ("Ordinary Shares") through Shard Capital Partners LLP.

Date of purchase:

09 May 2025

Number of Ordinary Shares purchased:

1,000,000

Highest price paid per share (GBP):

0.0145

Lowest price paid per share (GBP):

0.0145

Volume weighted average price paid (GBP):

0.0145

 

Notification of total voting rights in accordance with paragraph 5.6.1 of the FCA's Disclosure Guidance and Transparency Rules

The purchased Ordinary Shares will be held in treasury by the Company. The issued share capital of the Company is 492,952,784 Ordinary Shares, each share carrying the right to one vote, of which 23,810,000 are held in treasury. For reporting purposes under the FCA's Disclosure and Transparency Rules the market should exclude any shares held in treasury and should use the figure 469,142,784 as denominator for the calculations by which they may determine if they are required to notify their interest in, or a change to their interest in, the Company under the Company's Memorandum and Articles of Association.

The Company will make further announcements in due course following the completion of any further purchases pursuant to the Programme.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), the table below contains detailed information of the individual trades made by Shard Capital Partners LLP on behalf of the Company as part of the Programme. 

Individual transaction

Number of ordinary Shares

Transaction price (GBP share)

Time of transaction (UK time)

Trading venue

500,000

0.0145

15:43

AQSE

500,000

0.0145

14:24

AQSE

 

The Directors of Fenikso accept responsibility for this announcement. 

For further information please contact:

 

Fenikso Limited 

Thomas Richardson, Chairman

info@feniksoplc.com 

First Sentinel Corporate Finance Limited

Brian Stockbridge, Corporate Adviser

+44 7858 888 007

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXAJMLTMTBBBRA
Date   Source Headline
18th Jun 20267:00 amRNSAnnual results for the year ended 31 December 2025
13th May 20264:00 pmRNSReceipt of funds for repayment of US$51.9m loan
2nd Apr 20267:00 amRNSReceipt of funds for repayment of US$51.9m loan
6th Feb 202610:45 amRNSReceipt of funds for repayment of US$51.9m loan
31st Dec 20257:00 amRNSReceipt of funds for repayment of US$51.9m loan
31st Dec 20257:00 amRNSReceipt of funds for repayment of US$51.9m loan
24th Nov 20259:59 amRNSReceipt of funds for repayment of US$51.9m loan
5th Nov 20255:20 pmRNSTransaction In Own Shares
20th Oct 202512:58 pmRNSReceipt of funds for repayment of US$51.9m loan
6th Oct 20252:54 pmRNSTransaction In Own Shares
25th Sep 20254:01 pmRNSReceipt of funds for repayment of US$51.9m loan
25th Sep 20257:00 amRNSInterim Results
30th Jul 20257:00 amRNSReceipt of funds for repayment of US$51.9m loan
29th Jul 20251:09 pmRNSAGM Results
4th Jul 20257:00 amRNSNotice of AGM
18th Jun 20257:00 amRNSAnnual results for the year ended 31 December 2024
4th Jun 20257:00 amRNSReceipt of funds for repayment of US$51.9m loan
14th May 20257:00 amRNSTransaction In Own Shares
25th Apr 20258:57 amRNSRenegotiation of Savanah Investments Limited Loan
19th Mar 20257:00 amRNSReceipt of funds for repayment of US$51.9m loan
28th Feb 20255:32 pmRNSTransaction In Own Shares
31st Jan 20257:00 amRNSReceipt of funds for repayment of US$51.9m loan
12th Dec 20247:00 amRNSReceipt of funds for repayment of US$51.9m loan
6th Nov 20247:00 amRNSNotification of Investment
31st Oct 20241:28 pmRNSTR-1: Standard notification of major holdings
29th Oct 20245:32 pmRNSTransaction In Own Shares
28th Oct 20244:53 pmRNSTransaction In Own Shares
28th Oct 20247:00 amRNSReceipt of funds for repayment of US$51.9m loan
28th Oct 20247:00 amRNSShare Buyback Programme
30th Sep 20247:00 amRNSInterim Results
24th Sep 20247:00 amRNSReceipt of funds for repayment of US$51.9m loan
16th Aug 202410:29 amRNSNotification of First Investments
15th Aug 20247:00 amRNSReceipt of funds for repayment of US$51.9m loan
15th Aug 20247:00 amRNSResults of Annual General Meeting
12th Jul 20247:00 amRNSNotice of AGM
5th Jul 20247:00 amRNSReceipt of funds for repayment of US$51.9m loan
4th Jul 202410:35 amRNSTR-1: Standard notification of major holdings
27th Jun 20247:00 amRNSAnnual results for the year ended 31 December 2023
15th May 20247:00 amRNSReceipt of funds for repayment of US$51.9m loan
9th Apr 20249:25 amRNSReceipt of funds for repayment of US$51.9m loan
25th Jan 20247:00 amRNSReceipt of funds for repayment of US$51.9m loan
22nd Dec 20238:11 amRNSReceipt of funds for repayment of US$51.9m loan
28th Nov 20239:19 amRNSReceipt of funds for repayment of US$51.9m loan
30th Oct 20237:00 amRNSReceipt of funds for repayment of US$51.9m loan
26th Sep 20237:00 amRNSInterim Results
1st Sep 20231:29 pmRNSReceipt of funds for repayment of US$51.9m loan
2nd Aug 20235:36 pmRNSPartial Completion of Share Surrender
28th Jul 202312:09 pmRNSDirectorate Change
26th Jul 20235:06 pmRNSReceipt of funds for repayment of US$51.9m loan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.